Skip to main content
Type 2 Diabetes ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
Literature Review
MD-IQ
Pharmacology
Ranolazine and HbA1c and FPG
Fed Pract
. 2010 September;27(9):42
PDF Download
Recommended Reading
New Data Challenge 130 mm Hg As Systolic BP Target in Diabetes
Type 2 Diabetes ICYMI
Delay in Addressing Bleeding From Dialysis Access Site
Type 2 Diabetes ICYMI
Questioning the Long-Term Benefit of Aspirin in Patients with Diabetes
Type 2 Diabetes ICYMI
Another Defeat for Conventional Wisdom
Type 2 Diabetes ICYMI
Uncontrolled Diabetes Plus Hypertension: A Recipe for Dementia?
Type 2 Diabetes ICYMI
We Know Less than We Think, Part 2: Aspirin Therapy in Diabetes Not a Given After All
Type 2 Diabetes ICYMI
The Niacin Debate Continues: Higher Doses, Please
Type 2 Diabetes ICYMI
Eplerenone Decreases Hospitalization Time
Type 2 Diabetes ICYMI
Thick skin on the back
Type 2 Diabetes ICYMI
Coronary heart disease in people infected with HIV
Type 2 Diabetes ICYMI
Diabetes
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
Literature Review
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
Literature Review
MD-IQ
More
MDedge